Literature DB >> 6090110

Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells.

A De Léan, K Racz, J Gutkowska, T T Nguyen, M Cantin, J Genest.   

Abstract

The effect of synthetic atrial natriuretic factor (ANF) on adrenal steroidogenesis has been studied in primary culture of bovine adrenal cells. ANF-(8-33) produced a potent 40-70% inhibition of angiotensin II-, ACTH-, PGE1-, and forskolin-stimulated secretion of aldosterone production from zona glomerulosa cells with an ED50 of 120 pM. An equipotent inhibitory effect of the natriuretic factor on cortisol production was also observed in cultured zona fasciculata cells. Nicotine-stimulated secretion of catecholamines from medullary cells was only slightly inhibited by the factor at doses above 10 nM. [125I]iodo-ANF-(8-33) binding to glomerulosa membranes displayed an apparent affinity of 100-150 pM for specific receptor sites and was not inhibited by angiotensin II or ACTH. Conversely, the natriuretic factor had no affinity for angiotensin II receptor sites. The results demonstrate that part of the natriuretic effect of this new factor might be due to inhibition of adrenal steroidogenesis by action through a distinct receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090110     DOI: 10.1210/endo-115-4-1636

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Evolution of the membrane guanylate cyclase transduction system.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

3.  Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation.

Authors:  K N Pandey
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

4.  Raised plasma levels of atrial natriuretic peptides in Addison's disease.

Authors:  F P Cappuccio; N D Markandu; M G Buckley; A L Sugden; G A Sagnella; G A MacGregor
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

5.  An activator of protein kinase C (phorbol dibutyrate) attenuates atrial-natriuretic-factor-stimulated cyclic GMP accumulation in smooth-muscle cells.

Authors:  P Nambi; M Whitman; N Aiyar; F Stassen; S T Crooke
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

Review 6.  The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.

Authors:  E S Domurat; A N Elias
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

7.  Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; S Bountzioukas; K Mavroudis; M Karamouzis; O Guiba-Tziampiri
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

8.  Effect of human atrial natriuretic peptide on blood glucose concentrations and hormone stimulation during insulin-induced hypoglycaemia in healthy man.

Authors:  E Jungmann; C Konzok; E Höll; W Fassbinder; K Schöffling
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  [The heart as an endocrine organ: the discovery of a new hormone].

Authors:  R Gerzer
Journal:  Klin Wochenschr       Date:  1985-06-18

Review 10.  Interactions between atrial natriuretic factor and the autonomic nervous system.

Authors:  C C Lang; A D Struthers
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.